ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Osemitamab in combination with capecitabine and oxaliplatin (CAPOX) as a first line treatment of advanced G/GEJ cancer: Updated data of cohort C from a phase I/IIa, multi-center study (TranStar102/TST001-1002)

Shen, Lin; Liu, Dan; Li, Ning; Guo, Weijian; Liu, Tianshu; Li, Hongli; Li, Jiayi; Bai, Yuxian; Deng, Yanhong; Zhuang, Zhi-xiang; Sun, Meili; Fan, Qingxia; Zhao, Fuyou; Han, Liang; Xia, Zhenzhong; Wang, Jianming; Qi, Charlie; Xu, Li; Qian, Xueming; Germa, Caroline复旦大学; 哈尔滨医科大学; 郑州大学; 苏州大学; 厦门大学; 中山大学; 6; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)2023-6-1
11阅读
引用收藏
分享
相关
加载中…
  • Osemitamab plus capecitabine and oxaliplatin (CAPOX) as the first-line treatment of advanced G/GEJ cancer - updated efficacy data per claudin 18.2 expression level from study TranStar102/TST001-1002-cohort C
    Shen, L.; Liu, D.; Li, N.; Guo, W.; Liu, T.; Li, H.; Li, J.; Zhao, F.; Sun, M.; Bai, Y.; Deng, Y.; Zhuang, Z.; Fan, Q.; Han, L.; Xia, S.; Zhu, X.; Qi, C.; Xu, L.; Qian, X.; Germa, C.
  • KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1-selected populations
    Rha, Sun Young; Wyrwicz, Lucjan; Weber, Patricio Eduardo Yanez; Bai, Yuxian; Ryu, Min-Hee; Lee, Jeeyun; Rivera, Fernando; Alves, Gustavo Vasconcelos; Garrido, Marcelo; Shiu, Kai-Keen; Fernandez, Manuel Gonzalez; Li, Jin; Lowery, Maeve Aine; Cil, Timucin; Cruz, Felipe Melo; Qin, Shukui; Yin, Lina; Bordia, Sonal; Bhagia, Pooja; Oh, Do-YounAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.被引 4
  • Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study
    Rha, S. Y.*; Wyrwicz, L. S.; Weber, P. E. Y.; Bai, Y.; Ryu, M. H.; Lee, J.; Rivera, F.; Alves, G. V.; Garrido, M.; Shiu, K. -k.; Fernandez, M. Gonzalez; Li, J.; Lowery, M.; Cil, T.; Cruz, F. J. S. M.; Qin, S.; Yin, L.; Bordia, S.; Bhagia, P.; Oh, D-y.Annals of Oncology, 2023, 34(3): 319-320.被引 26
查看全部 →

会议信息

会议名称
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
会议日期
2023-06-02 至 2023-06-06
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2023-06-01
资助标注
Suzhou Transcenta Therapeutics Co., Ltd.
收录
ISTP · SCIE

作者

  • S

    Shen, Lin (第一作者)

  • L

    Liu, Dan

查看全部 20 位作者收起作者
  • L

    Li, Ning

  • G

    Guo, Weijian

  • L

    Liu, Tianshu

  • L

    Li, Hongli

  • L

    Li, Jiayi

  • B

    Bai, Yuxian

  • D

    Deng, Yanhong

  • Z

    Zhuang, Zhi-xiang

  • S

    Sun, Meili

  • F

    Fan, Qingxia

  • Z

    Zhao, Fuyou

  • H

    Han, Liang

  • X

    Xia, Zhenzhong

  • W

    Wang, Jianming

  • Q

    Qi, Charlie

  • X

    Xu, Li

  • Q

    Qian, Xueming

  • G

    Germa, Caroline

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417